Rheumatology
Conference Coverage
Structural changes may separate axial psoriatic arthritis from axial spondyloarthritis
Approximately two-thirds of patients met criteria for both conditions, but imaging data show distinctions.
Feature
Axial spondyloarthritis: Does visibility with x-rays make a difference in management?
“Axial spondyloarthritis is one disease, and whether it is radiographic or nonradiographic makes zero difference in the management of the patient...
Feature
Diagnosing chronic back pain: When to suspect axial spondyloarthritis
Worldwide, the average time to diagnosis was found to be up to 6 years, but patient advocacy groups say the delay can be up to 10 years or more....
Latest News
Study validates use of new psoriatic arthritis prediction tool
To develop the tool, researchers evaluated 635 patients with psoriasis from a prospective longitudinal cohort study evaluating risk factors for...
Latest News
Gout: Suboptimal management a continuing problem
Pipeline drugs show promise but undertreatment, poor adherence reduce efficacy of current therapies.
From the Journals
Autoantibody against enteric nervous system protein linked to GI dysfunction in systemic sclerosis
If validated as a biomarker, antigephyrin autoantibodies could help identify patients at higher risk for GI symptoms like constipation.
From the Journals
Low-dose steroids may not increase cardiovascular risk in rheumatoid arthritis
A daily prednisolone dose of less than 5 mg was not associated with increased cardiovascular risk, whereas a dose of 5 mg or more doubled the risk...
From the Journals
Tools may predict inflammatory arthritis in at-risk patients
The two tool scores could help determine who can be managed in primary care and who may qualify for intervention studies.
From the Journals
Could risk stratifying methotrexate users lead to less frequent testing?
A new prognostic model accurately predicts a patient’s risk of experiencing methotrexate toxicity, but more research is needed before clinical...
Feature
Could GLP-1 receptor agonists ease knee osteoarthritis pain, slow progression?
Weight loss is recommended for patients with knee osteoarthritis (KOA), and GLP-1 RAs are approved for weight loss. Early research suggests these...
From the Journals
SGLT2 inhibitors linked with fewer gout flares in diabetes
“SGLT2 inhibitors may offer distinct benefits,” making the drug class “a particularly attractive addition to current urate-lowering therapies.”